• Wolters Kluwer research highlights accelerating healthcare adoption of AI-enabled medication workflows, despite consumer concerns over trust and human oversight.
• Among healthcare professionals surveyed, 99% report their organizations are moving toward AI-enabled medication workflows.
• Meanwhile, 98% expect organizational reliance on curated, continually updated medication intelligence to increase as workflows become more automated.
• Only 27% of consumers strongly trust automated systems to flag potential drug interactions correctly without direct healthcare professional involvement.
• Reflecting that caution, 68% would independently verify AI-generated medication details always or most of the time.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wolters Kluwer NV published the original content used to generate this news brief on November 05, 2026, and is solely responsible for the information contained therein.